Forecast & Rating4 analysts currently cover Inhibrx Biosciences, of which 3 give a positive rating. The average price target is $266.67, about 162.0% upside from the current price of $101.77. Coverage is limited, so the data is for reference only. Data as of Sep 9, 2026; this does not constitute investment advice.
Sep 9, 2026Price forecast
$266.67162.03%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met50.7%
Stock price$101.77
Avg. target$266.7
High target$325
Low target$230
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.